Why is Remedium Life falling/rising?

As of 08-Aug, Remedium Lifecare Ltd's stock price is currently at 1.21, reflecting a decrease of 0.02, or 1.63%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 7.63% over that period. Additionally, the stock's performance today has underperformed its sector by 1.35%. The delivery volume has significantly decreased, with a drop of 93.34% compared to the five-day average, indicating falling investor participation. The stock's returns over various periods show a stark decline, with a year-to-date drop of 66.15% and an annual decline of 85.62%, although it has shown some recovery over the last three and five years.
In the broader market context, the Sensex has also experienced a slight decline of 0.92% over the past week, but it has performed better than Remedium Lifecare Ltd, which has seen a much steeper decline. While the stock has outperformed the benchmark over the last month with a gain of 7.08%, its year-to-date and one-year performances are significantly worse than the Sensex, which has gained 2.20% and 1.23%, respectively. This contrast highlights the challenges faced by Remedium Lifecare Ltd in maintaining investor confidence and attracting participation in a market that is not entirely unfavorable.